No­vo Hold­ings picks up in­jecta­bles CD­MO in push for sin­gle-use man­u­fac­tur­ing tech

For 25 years, Rite­dose has been a CD­MO that’s pro­vid­ed ster­ile, asep­tic pro­duc­tion of sin­gle-dose med­ica­tion for more than 8 bil­lion dos­es. No­vo Hold­ings has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER